Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaolin Ma

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Medcomm|July 6, 2023
Correlations between the viral loads and symptoms in the SARS-CoV-2-infected patientsXiaomin Wang, Shaolin Ma, Bing Zhao, et al.
Current Stem Cell Research & Therapy|October 28, 2025
Bibliometric Analysis of MSC-based Therapies for Non-COVID-19 ARDSShengyu Huang, Dan Wang, Yusong Wang, et al.
BMC Nephrology|November 13, 2024
Factors and machine learning models for predicting successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury: a retrospective cohort study based on MIMIC-IV databaseShuyue Sheng, Andong Li, Xiaobin Liu, et al.
BMC Cancer|December 19, 2024
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancerChuying Huo, Bin Wu, Dongdong Ye, et al.
Oncotarget|October 28, 2015
Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cellsFang Wang, Yifan Chen, Lihua Huang, et al.
Gynecologic Oncology|August 15, 2021
MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancerYutuan Wu, Jie Huang, Cristina Ivan, et al.
Journal of General Internal Medicine|January 27, 2021
Changing Paradigm for Vertigo/Dizziness Patients: a Retrospective Before-After Study from Tertiary Hospitals in Northwestern ChinaPeng Liu, Shaolin Ma, Guixiang Du, et al.
Journal of Intensive Medicine|August 3, 2023
Expert consensus on blood pressure management in critically ill patientsYuetian Yu, Ye Gong, Bo Hu, et al.
Oncotarget|August 6, 2020
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancerOlivia D Lara, Emine Bayraktar, Paola Amero, et al.
Cancers|July 27, 2022
Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian CancerLi Zhao, Sara Corvigno, Shaolin Ma, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Medcomm|July 6, 2023
Correlations between the viral loads and symptoms in the SARS-CoV-2-infected patientsXiaomin Wang, Shaolin Ma, Bing Zhao, et al.
Current Stem Cell Research & Therapy|October 28, 2025
Bibliometric Analysis of MSC-based Therapies for Non-COVID-19 ARDSShengyu Huang, Dan Wang, Yusong Wang, et al.
BMC Nephrology|November 13, 2024
Factors and machine learning models for predicting successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury: a retrospective cohort study based on MIMIC-IV databaseShuyue Sheng, Andong Li, Xiaobin Liu, et al.
BMC Cancer|December 19, 2024
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancerChuying Huo, Bin Wu, Dongdong Ye, et al.
Oncotarget|October 28, 2015
Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cellsFang Wang, Yifan Chen, Lihua Huang, et al.
Gynecologic Oncology|August 15, 2021
MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancerYutuan Wu, Jie Huang, Cristina Ivan, et al.
Journal of General Internal Medicine|January 27, 2021
Changing Paradigm for Vertigo/Dizziness Patients: a Retrospective Before-After Study from Tertiary Hospitals in Northwestern ChinaPeng Liu, Shaolin Ma, Guixiang Du, et al.
Journal of Intensive Medicine|August 3, 2023
Expert consensus on blood pressure management in critically ill patientsYuetian Yu, Ye Gong, Bo Hu, et al.
Oncotarget|August 6, 2020
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancerOlivia D Lara, Emine Bayraktar, Paola Amero, et al.
Cancers|July 27, 2022
Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian CancerLi Zhao, Sara Corvigno, Shaolin Ma, et al.
Pageof 6